Kallenbach J M, Joffe B I, Seftel H C, Zwi S
S Afr Med J. 1984 Jan 28;65(4):131-4.
The role of the alpha-adrenergic system in the pathogenesis of asthma is investigated. We administered 150 micrograms oral clonidine to a group of patients with relatively mild asthma and a group of non-asthmatic subjects, and compared their responses by measuring plasma levels of growth hormone (GH), immunoreactive insulin, potassium and glucose. There was no significant difference between the groups in respect of any of these variables, nor was there a significant difference in the blood pressure responses. However, 3 of the asthmatic subjects demonstrated marked hyper-responsiveness of the plasma GH levels after clonidine. It is possible that increased alpha-adrenergic responses may be more frequently demonstrable in a group of severe asthmatics or by means of an alpha-agonist which is more potent and less selective than clonidine. Alternatively, the 3 hyper-responsive individuals may represent a subgroup of asthmatics in whom alpha-adrenergic overactivity is an important pathogenetic mechanism.
研究了α-肾上腺素能系统在哮喘发病机制中的作用。我们给一组病情相对较轻的哮喘患者和一组非哮喘受试者口服150微克可乐定,并通过测量血浆生长激素(GH)、免疫反应性胰岛素、钾和葡萄糖水平来比较他们的反应。在这些变量方面,两组之间没有显著差异,血压反应也没有显著差异。然而,3名哮喘受试者在服用可乐定后血浆GH水平表现出明显的高反应性。在一组重度哮喘患者中,或者通过一种比可乐定更有效且选择性更低的α-激动剂,可能更频繁地表现出α-肾上腺素能反应增强。另外,这3名高反应性个体可能代表了哮喘患者中的一个亚组,其中α-肾上腺素能活动过度是一个重要的发病机制。